Credo
Overview
Credo Health is a precision care management company based in Bengaluru, India, and Denver, USA, founded in 2020. The company provides innovative chronic condition management services through a blend of AI technology and personalized human care. Led by founders Leo Ananth and Carm Huntress, Credo Health has secured significant investment, including a $5.25 million series seed funding round. Its platforms, like the PreDx product, offer AI-driven analysis of medical records to support value-based care.
Recent Developments
- May 2025: Credo Health announced that current revenue projections for the fourth quarter of fiscal 2025 show expected earnings between $155 million to $165 million, indicating strong sequential growth across its product lines.
- March 2025: Credo Health highlighted record revenue and significant growth at the Optical Fiber Communication (OFC) conference. The AEC product line, in particular, showed robust demand, underscoring Credo’s leadership in the connectivity solutions market.
- February 2025: The company focused on AI-driven healthcare solutions, presenting its refined interoperability processes and new partnerships aimed at enhancing digital medical record management.
- January 2025: Credo Health's AI governance capabilities were showcased, marking the implementation of significant AI regulations and their impact on the healthcare technology landscape.
- October 2024: The company expanded its market presence by enhancing electronic health record (EHR) workflows through partnerships, notably its collaboration with Vim, improving healthcare outcomes by leveraging AI-powered medical analysis.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2020 |
| Headquarters | Bengaluru, India & Denver, USA |
| Founders | Leo Ananth, Carm Huntress |
| Revenue | $18.6K (2022) |
| Funding | $8.25M across multiple rounds |
| Industry | Healthcare Technology |
| Number of Employees | 41 (as of October 2024) |
| Key Investors | FCA Venture Partners, FirstMile Ventures, Hannah Grey VC |
Early History
Credo Health was founded in 2020 by Leo Ananth in Bengaluru and Carm Huntress in Denver, driven by a mission to improve chronic disease management through technological innovation. From its inception, the company aimed to bridge gaps in healthcare using AI and digital solutions. Early support from venture partners enabled the development of their flagship product, the PreDx platform, which quickly became a cornerstone of their offering. Their focus on personalized precision care, coupled with seamless integration of AI technology into traditional health pathways, helped establish their credibility and attracted initial investment rounds.
Company Profile and Achievements
Credo Health offers a digital therapeutic platform powered by AI, providing services such as diabetes management, hypertension management, and cardiac wellness. Their business model centers on leveraging technology to blend precision care with human touch, ensuring high standards of health management. Key achievements include:
- Launch of PreDx Platform: Enabled providers to access comprehensive patient data, supporting accurate healthcare decisions.
- Collaborations and Partnerships: Strategic partnerships with HealthMark Group and Vim to enhance medical record retrieval and EHR integration.
- Funding and Growth: Successfully closed multiple funding rounds, strengthening their market position and enabling expansive service offerings.
- Industry Recognition: Recognition for their innovative approaches in healthcare management, facilitating progress in data-driven health services.
Current Operations and Market Position
Currently operating in both India and the USA, Credo Health caters to healthcare providers, health plans, and managed service organizations (MSOs) with a focus on value-based care solutions. Their competitive advantage lies in integrating AI for efficient management of chronic conditions, addressing inefficiencies in healthcare delivery systems. Credo has positioned itself at the forefront of healthcare tech by ensuring seamless operations across digital and human interfaces, expanding its influence in the market through continuous product and strategic advancements.
Related Topics
This section is omitted as there were no related searches provided.
Conclusion
Credo Health represents a significant force in healthcare technology, demonstrating the potential of AI-integrated solutions for chronic disease management. With a strong foundation in precision care, the company continues to push boundaries in healthcare innovation. Its strategic partnerships and comprehensive funding have positioned Credo Health as a leader in the digital transformation of healthcare services. Looking ahead, Credo’s focus on expanding its technological capabilities and market reach suggests a promising trajectory aimed at transforming value-based care delivery.